MAOB and Parkinson disease: In this study, the bioactive fraction PG50 exhibited the highest inhibitory activity against the MAO-B enzyme in vitro among all the fractions, and its neuroprotective effect was subsequently evaluated in vivo using a rotenone-induced PD rat model.